Novel agents for KRAS-mutant NSCLC

被引：0
|
作者：
Janne, Pasi A. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.477
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY20-1
引用
收藏
页码：S444 / S444
页数：1
相关论文
共 50 条
  • [21] Osteopontin drives KRAS-mutant lung adenocarcinoma
    Giopanou, Ioanna
    Kanellakis, Nikolaos, I
    Giannou, Anastasios D.
    Lilis, Ioannis
    Marazioti, Antonia
    Spella, Magda
    Papaleonidopoulos, Vassilios
    Simoes, Davina C. M.
    Zazara, Dimitra E.
    Agalioti, Theodora
    Moschos, Charalampos
    Magkouta, Sophia
    Kalomenidis, Ioannis
    Panoutsakopoulou, Vily
    Lamort, Anne-Sophie
    Stathopoulos, Georgios T.
    Psallidas, Ioannis
    CARCINOGENESIS, 2020, 41 (08) : 1134 - 1144
  • [22] Closing the door on KRAS-mutant lung cancer
    Megan Cully
    Nature Reviews Drug Discovery, 2016, 15 : 747 - 747
  • [23] Current therapy of KRAS-mutant lung cancer
    Ghimessy, Aron
    Radeczky, Peter
    Laszlo, Viktoria
    Hegedus, Balazs
    Renyi-Vamos, Ferenc
    Fillinger, Janos
    Klepetko, Walter
    Lang, Christian
    Dome, Balazs
    Megyesfalvi, Zsolt
    CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1159 - 1177
  • [24] Genetic modifiers of KRAS-mutant colorectal cancer
    Tjader, Nijole P.
    Ramroop, Johnny
    Gandhi, Tanish
    Campbell, Peter T.
    Chan, Andrew T.
    Gallinger, Steven
    Giles, Graham G.
    Gunter, Marc J.
    Harrison, Tabitha A.
    Hoffmeister, Michael
    Newcomb, Polly A.
    Ogino, Shuji
    Phipps, Amanda I.
    Qu, Conghui
    Schoen, Robert E.
    Pellatt, Andrew
    Woods, Michael O.
    Van Guelpen, Bethany
    Stevens, Patrick
    Hampel, Heather
    Peters, Ulrike
    McElroy, Joseph P.
    Toland, Amanda E.
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Role of silent mutations in KRAS-mutant tumors
    Lu, Jun
    Zhou, Chao
    Pan, Feng
    Liu, Hongyu
    Jiang, Haohua
    Zhong, Hua
    Han, Baohui
    CHINESE MEDICAL JOURNAL, 2025, 138 (03) : 278 - 288
  • [26] Novel Polymethoxylated Chalcones as Potential Compounds Against KRAS-Mutant Colorectal Cancers
    Mahmoud, Alaa
    Elkhalifa, Dana
    Alali, Feras
    Al Moustafa, Ala-Eddin
    Khalil, Ashraf
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (14) : 1622 - 1633
  • [27] Ephrins/eph as novel synthetic lethal targets in Kras-mutant colorectal cancer
    Van Schaeybroeck, S.
    Allen, W. L.
    Dunne, P.
    Jithesh, P.
    Longley, D.
    Johnston, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Current therapy of KRAS-mutant lung cancer
    Aron Ghimessy
    Peter Radeczky
    Viktoria Laszlo
    Balazs Hegedus
    Ferenc Renyi-Vamos
    Janos Fillinger
    Walter Klepetko
    Christian Lang
    Balazs Dome
    Zsolt Megyesfalvi
    Cancer and Metastasis Reviews, 2020, 39 : 1159 - 1177
  • [29] Progress for KRAS mutant NSCLC
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2013, 10 (2) : 66 - 66
  • [30] Real-world Data from KRAS-mutant Advanced NSCLC: the ATLAS Multicenter Cohort Study
    Bungaro, M.
    Garbo, E.
    Jacobs, F.
    Reale, M. L.
    Passiglia, F.
    Tiseo, M.
    Genova, C.
    Galetta, D.
    Malapelle, U.
    Troncone, G.
    Novello, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S449 - S449
12345